Clinical Trials on Bullous Dermatoses in United Kingdom
Total 183 results
-
University of NebraskaRecruiting
-
Wake Forest UniversityCompletedHand DermatosisUnited States
-
Stiefel, a GSK CompanyGlaxoSmithKlineCompletedHand DermatosisUnited States
-
DermBiont, Inc.Active, not recruitingDermatosis Papulosa NigraUnited States
-
Aclaris Therapeutics, Inc.CompletedDermatosis Papulosa NigraUnited States
-
University of California, DavisCompleted
-
Patel, Rita Vikram, M.D.Ranbaxy Inc.CompletedAcute Steroid Responsive Dermatoses | Chronic Steroid Responsive DermatosesUnited States
-
Henry Ford Health SystemRecruitingLichen Planus Pigmentosus | Erythema Dyschromicum Perstans | Ashy Dermatosis of RamirezUnited States
-
King's College LondonUnknownRecessive Dystrophic Epidermolysis BullosaUnited Kingdom
-
ZARS Pharma Inc.CompletedHand DermatosesUnited States
-
King's College LondonUniversity College, LondonCompletedRecessive Dystrophic Epidermolysis BullosaUnited Kingdom
-
Institut National de la Santé Et de la Recherche...UnknownRecessive Dystrophic Epidermolysis BullosaFrance, United Kingdom
-
argenxRecruitingBullous PemphigoidNetherlands, Spain, Germany, United Kingdom, China, Italy, Hungary, United States, Croatia, Japan, Serbia, Bulgaria, Israel, Australia, Greece, Slovakia
-
University of IowaGenentech, Inc.Completed
-
Mayo ClinicEli Lilly and CompanyCompleted
-
University Hospital Birmingham NHS Foundation TrustUniversity of Birmingham; Dystrophic Epidermolysis Bullosa Research Association...Enrolling by invitationJunctional Epidermolysis Bullosa | Laryngo Onycho Cutaneous SyndromeUnited Kingdom
-
University of California, DavisNot yet recruitingBullous PemphigoidUnited States
-
Emory UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Duke UniversityGenentech, Inc.Completed
-
RHEACELL GmbH & Co. KGFGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & ServicesCompletedRecessive Dystrophic Epidermolysis BullosaUnited States, Austria, France, Germany, United Kingdom
-
Eli Lilly and CompanyNo longer availableChronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE) | Juvenile Dermatomyositis (JDM) | Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI) | Aicardi-Goutières Syndrome (AGS)United States, United Kingdom
-
KDRS ltdRecruitingVulvar Diseases | Vulvar Atrophy | DermatosesUnited Kingdom
-
University of DundeeEmblation LimitedCompletedActinic Keratoses | Precancerous Skin LesionUnited Kingdom
-
argenxActive, not recruitingBullous PemphigoidUnited States, Australia, Bulgaria, China, Croatia, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Latvia, Netherlands, Poland, Romania, Serbia, Slovakia, Spain, United Kingdom
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Cardiff University; University of SurreyCompleted
-
Royal Cornwall Hospitals TrustSuspendedActinic Keratoses | Photodamaged SkinUnited Kingdom
-
Novartis PharmaceuticalsTerminatedBullous PemphigoidTaiwan, Germany, United States, Japan, Austria, France
-
University of PennsylvaniaRecruitingBullous Pemphigoid | Pemphigus Vulgaris | Pemphigus FoliaceusUnited States
-
Chelsea and Westminster NHS Foundation TrustUnknownBullous EmphysemaUnited Kingdom
-
Regeneron PharmaceuticalsSanofiActive, not recruitingBullous PemphigoidUnited States, Japan, Germany, Australia, France, Israel, Poland, Spain, Taiwan
-
Institute of Child HealthCompleted
-
AKARI TherapeuticsWithdrawnBullous PemphigoidUnited States, Germany, Netherlands, Poland
-
AstraZenecaTerminatedBullous PemphigoidFrance, Italy, Spain, Germany, United States, Australia, China, Bulgaria, Israel, Japan, Greece
-
Castle Creek Pharmaceuticals, LLCCompletedDystrophic Epidermolysis Bullosa | Epidermolysis Bullosa Simplex | Junctional Epidermolysis Bullosa | Epidermolysis Bullosa (EB)United States
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedTinea PedisPoland, United Kingdom
-
West Virginia UniversityWithdrawn
-
Krystal Biotech, Inc.CompletedDystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis Bullosa | DEB - Dystrophic Epidermolysis BullosaUnited States
-
Lenus Therapeutics, LLCTerminatedDystrophic Epidermolysis Bullosa | Junctional Epidermolysis BullosaUnited States
-
Spirig Pharma Ltd.TerminatedActinic Keratoses | Squamous Cell CarcinomasIreland, Austria, Netherlands, United Kingdom, Czech Republic, France, Germany, Switzerland, Turkey
-
Krystal Biotech, Inc.RecruitingDystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis BullosaUnited States
-
Stanford UniversityRecruitingEpidermolysis Bullosa DystrophicaUnited States
-
Castle Creek Biosciences, LLC.TerminatedEpidermolysis Bullosa Dystrophica, RecessiveUnited States
-
University of Southern CaliforniaRecruitingRecessive Dystrophic Epidermolysis BullosaUnited States
-
Joyce TengRecruitingHealthy | Epidermolysis Bullosa | Genetic Skin Disease | Epidermolysis Bullosa Dystrophica | Epidermolysis Bullosa Simplex | Epidermolysis Bullosa, JunctionalUnited States
-
Stanford UniversityTerminatedEpidermolysis Bullosa DystrophicaUnited States
-
University of California, IrvineTerminated
-
Krystal Biotech, Inc.CompletedDystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis BullosaUnited States
-
Phoenix Tissue Repair, Inc.CompletedRecessive Dystrophic Epidermolysis BullosaUnited States
-
Abeona Therapeutics, IncNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedEpidermolysis Bullosa | Epidermolysis Bullosa DystrophicaUnited States
-
University of Southern CaliforniaCompleted